FDA
Home Page | CDRH Home Page | Search
| CDRH
A-Z Index | Contact CDRH
|
IntraStent® DoubleStrut™ Stent- P030045 |
This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval.
Product Name: IntraStent DoubleStrut Stent
Manufacturer: ev3 Inc.
Address: 4600 Nathan Lane North
Plymouth, MN 55442-2920
Approval Date: June 8, 2004
Approval Letter: http://www.fda.gov/cdrh/pdf3/p030045a.pdf
What is it? The IntraStent DoubleStrut Stent is a thin, flexible metal mesh tube that can be implanted in the large arteries that supply blood to the pelvis and legs (iliac arteries). The IntraStent acts like a scaffold by holding an iliac artery open to maintain adequate blood flow.
When is it used? The IntraStent is used to treat patients with narrowing of an iliac artery caused by atherosclerosis, the collection of fatty substances such as cholesterol that forms “plaque” along the lining of the arteries.
How does it work?
What will it accomplish? The inside lining of the artery will grow over the stent approximately 8 weeks after it is implanted. Once in place, the stent acts as a scaffold to:
When should it not be used? There are no contraindications for this device.
Additional information: Summary of Safety and Effectiveness and labeling will be available at: http://www.fda.gov/cdrh/pdf3/p030045.html
Other:
Updated June 14, 2004
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH